Diagnostic News and Research

RSS

LUMEDX announces latest addition to its CardioPACS imaging solution

LUMEDX, a leading provider of fully integrated cardiovascular information systems, announces the latest addition to its CardioPACS imaging solution: an interface to QLAB, proprietary ultrasound software from Philips. Through Philips’ QLAB advanced 2D and 3D ultrasound quantification tools within the LUMEDX CardioPACS application, facilities using Philips ultrasound systems can now enjoy greater efficiencies and enhanced accuracy of diagnosis.

12 Mar 2010

Neoprobe meets with FDA to review Phase 3 clinical trial results of Lymphoseek drug

Neoprobe Corporation, a diversified developer of innovative oncology and surgical diagnostic and treatment products, today announced that it recently met with the United States Food and Drug Administration to review the clinical trial results of a Phase 3 investigational new drug, Lymphoseek®.

12 Mar 2010

TechniScan utilizes NVIDIA Tesla GPUs in WBU system for diagnostic breast imaging

TechniScan, Inc. is featured on NVIDIA's recently posted blog about speeding the amount of time it takes to get breast imaging results into the hands of doctors and patients. NVIDIA is the world leader in visual computing technologies and inventor of the graphics processing unit.

12 Mar 2010

CardioGenics Holdings offers further update on Merck Chimie agreement status

CardioGenics Holdings Inc., a developer of technology and products targeting the IVD segment of the Point-Of-Care (POC) diagnostic market, announced today a further update regarding the status of its agreement with Merck Chimie s.a.s.

12 Mar 2010

Study questions frequency of heart angiograms

A recent study raises questions about the frequency of doctors' use of elective heart angiograms, which showed no disease in almost 40 percent of patients. BusinessWeek reports: "Doctors may be sending patients too quickly for elective angiograms to detect heart disease, exposing them to radiation and driving up U.S. health-care costs, a study suggests.

12 Mar 2010

Covidien to use FDA, Health Canada approved Mo 99 from Maria for manufacturing Tc 99m generators

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) and Health Canada have approved the use of the Maria Research Reactor (Maria) in Poland as a site to irradiate highly-enriched uranium targets for Molybdenum 99 (Mo 99) production. Covidien will use the Mo 99 obtained from Maria in the manufacture of its Technetium 99m (Tc 99m) generators. Patients should begin to benefit from Maria-produced Mo 99 in the United States and Canada later this month.

12 Mar 2010

Tel Aviv University investigates cause and effects of SCA syndrome

Sudden Cardiac Arrest syndrome (SCA) is poorly understood, but it's a real danger for the otherwise young and healthy. For no apparent reason, the heart suddenly stops beating, and without treatment death may follow within minutes. It's why some athletes drop dead on the track and why a young man, without any warning, suddenly dies while sitting at his desk.

11 Mar 2010

DenMat's LUMINEERS Smile Design Studio to produce Snap-On Smile

DenMat Holdings, LLC, has recently announced its acquisition of the Snap-On Smile® brand and all intellectual property surrounding it. Snap-On Smile will be produced exclusively by DenMat's LUMINEERS® Smile Design Studio, an ISO 9001 certified laboratory offering a comprehensive range of superior esthetic and restorative services.

11 Mar 2010

Safeguard Scientifics' aggregate partner company revenue rises 46% in 2009

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the year was $262 million, up 46% from $179 million in 2008, exceeding the company’s 2009 guidance of $223 million to $243 million, as adjusted to reflect the inclusion of two new partner companies.

11 Mar 2010

Senetek closes Security Purchase Agreement with DMRJ

Senetek PLC today announced the closing of a Security Purchase Agreement, a Note and a Warrant Purchase Agreement DMRJ Group, LLC on March 4, 2010. DMRJ Group, LLC is a Delaware limited liability company affiliated with Platinum Partners Value Arbitrage Fund L.P., an accredited institutional investor with its investment manager headquartered in New York, New York.

11 Mar 2010

ADI’s 20-bit DAC enables superior image clarity, resolution, and contrast in medical imaging systems

MRI (magnetic resonance imaging) scans provide extraordinarily clear images of the human body and are commonly used to diagnose a wide range of illnesses and injuries, such as Alzheimer’s disease, cancerous tumors, and torn ligaments. Analog Devices, Inc., the leading provider of data conversion technology and longtime collaborator with the medical imaging industry, today introduced a breakthrough in data conversion that gives clinicians and radiologists the superior image clarity they need to see smaller anatomical structures and abnormalities, such as breast cancer cells, than ever before.

11 Mar 2010

Investigators develop new mathematical approach to analyze molecular data

Investigators have developed a new mathematical approach to analyze molecular data derived from complex mixtures of immune cells. This approach, when combined with well-established techniques, readily identifies changes in small samples of human whole blood, and has the potential to distinguish between health and disease states.

11 Mar 2010

WHO issues new guidelines for malaria treatment

The World Health Organization (WHO) is releasing new guidelines for the treatment of malaria, and the first ever guidance on procuring safe and efficacious anti-malarial medicines.

11 Mar 2010

West Coast Neurodiagnostics & MRI announces name change to Coast2Coast Diagnostics

West Coast Neurodiagnostics & MRI, a leading network of top-notch diagnostic centers with board-certified physicians, today announced it has become Coast2Coast Diagnostics (C2C). The name change represents a nationwide expansion of the company’s renowned network and underscores its commitment to being the affordable, efficient choice for specialty medical care delivery.

11 Mar 2010

WHO's updated malaria guidelines include rapid diagnosis, new ACT

The WHO on Tuesday released new guidelines for the treatment of malaria, which recommend "parasitological testing before treatment begins" and add "a new artemisinin based combination treatment [ACT] to the list of prescribed drugs," BMJ News reports.

11 Mar 2010

Scientists identify specific causative genetic mutation associated with CMT

Scientists using advanced genomic analysis technologies from Life Technologies Corporation have sequenced an individual’s genome and identified the specific causative mutation associated with Charcot-Marie-Tooth Disease (CMT), one of the most common inherited neurological disorders currently affecting 1 in 2,500 individuals in the United States.

11 Mar 2010

Insight Imaging commences operations in partnership with ARA in the Dallas metro-area

InSight Health Services Holdings Corp. announced today that it has commenced operations in partnership with American Radiology Associates, P.A. in the Dallas metro-area. Insight Imaging will manage the partnership, which has acquired ARA’s Willowbend Diagnostic Imaging Center. ARA has also agreed to provide professional services in the coming months at Insight Diagnostic Center – Forest Lane.

11 Mar 2010

Study supports Myriad Genetics' PROLARIS molecular diagnostic test for predicting prostate cancer recurrence

Myriad Genetics, Inc. today said data that provides further clinical validation supporting its newest molecular diagnostic product, PROLARIS™, was recently presented at the 2010 Genitourinary Cancers Symposium in San Francisco. The abstract of the presentation entitled: "Cell Cycle Genes Predict Recurrence After Radical Prostatectomy" by Gregory P. Swanson, M.D., University of Texas Health Science Center San Antonio, and colleagues is now available on the American Society of Clinical Oncology's website, www.asco.org.

11 Mar 2010

PBI and TDI announce strategic licensing and collaborative research and development agreement

Pressure BioSciences, Inc. and Target Discovery, Inc.,, today announced a strategic product licensing, manufacturing, co-marketing, and collaborative research and development agreement. Under the terms of the Agreement, PBI has been licensed by TDI to manufacture and sell a highly innovative line of chemicals used in the preparation of tissues for scientific analysis.

11 Mar 2010

Cardiologists to highlight capabilities of InfraReDx' LipiScan Coronary Imaging System at ACC.10 and i2 Summit

InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, today announced that the Company's LipiScan™ Coronary Imaging System will be highlighted in multiple sessions during the 59th Annual Scientific Session of the American College of Cardiology.

11 Mar 2010

Diagnostic News and Research

LUMEDX announces latest addition to its CardioPACS imaging solution

Neoprobe meets with FDA to review Phase 3 clinical trial results of Lymphoseek drug

TechniScan utilizes NVIDIA Tesla GPUs in WBU system for diagnostic breast imaging

CardioGenics Holdings offers further update on Merck Chimie agreement status

Study questions frequency of heart angiograms

Covidien to use FDA, Health Canada approved Mo 99 from Maria for manufacturing Tc 99m generators

Tel Aviv University investigates cause and effects of SCA syndrome

DenMat's LUMINEERS Smile Design Studio to produce Snap-On Smile

Safeguard Scientifics' aggregate partner company revenue rises 46% in 2009

Senetek closes Security Purchase Agreement with DMRJ

ADI’s 20-bit DAC enables superior image clarity, resolution, and contrast in medical imaging systems

Investigators develop new mathematical approach to analyze molecular data

WHO issues new guidelines for malaria treatment

West Coast Neurodiagnostics & MRI announces name change to Coast2Coast Diagnostics

WHO's updated malaria guidelines include rapid diagnosis, new ACT

Scientists identify specific causative genetic mutation associated with CMT

Insight Imaging commences operations in partnership with ARA in the Dallas metro-area

Study supports Myriad Genetics' PROLARIS molecular diagnostic test for predicting prostate cancer recurrence

PBI and TDI announce strategic licensing and collaborative research and development agreement

Cardiologists to highlight capabilities of InfraReDx' LipiScan Coronary Imaging System at ACC.10 and i2 Summit

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News